Aerie Pharmaceuticals, Inc. (Nasdaq: AERI) announced that it has commenced a registered underwritten public offering of $50 million of shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE